Literature DB >> 9878175

Recruitment of several neuroprotective pathways after permanent focal ischemia in mice.

C Guégan1, I Ceballos-Picot, A Nicole, H Kato, B Onténiente, B Sola.   

Abstract

After an ischemic episode induced by the electrocoagulation of the left middle cerebral artery (MCA) in mouse, neurons within the damaged territory die either by an apoptotic or by a necrotic process. Most of the cortical neurons within the ischemic area display both morphological and biochemical signs of programmed cell death: nuclear condensation, DNA degradation, formation of apoptotic bodies, and glutathione depletion. In fact, apoptosis essentially contributes to the expansion of the ischemic lesion and the maximum of damaged territory is reached 24 h postocclusion. Several potentially neuroprotective pathways have been evidenced in different experimental models of ischemia including the activation of antioxidant enzyme activities and/or the recruitment of neurotrophic as well as antiapoptotic factors. In our model of permanent focal ischemia induced by MCA occlusion, we measured the temporal synthesis of nerve growth factor (NGF) and examined the status of antioxidant enzymes as well as Bcl-2 antiapoptotic product. We detected in both cortices a transient increase of NGF which peaks at 6 h. Moreover, we reported that glutathione peroxidase is recruited with a time course which parallels NGF synthesis. Finally, we observed the induction of Bcl-2 in safe neurons; this may represent a self-protective response against ischemia-induced apoptosis. We provide evidence that in a model of permanent focal ischemia, several neuroprotective pathways could be coactivated. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878175     DOI: 10.1006/exnr.1998.6913

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM-36, results in profound inhibition of neuronal apoptosis.

Authors:  J K Callaway; P M Beart; B Jarrott; S F Giardina
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Pilot results of in vivo brain glutathione measurements in stroke patients.

Authors:  Li An; Krishna A Dani; Jun Shen; Steven Warach
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-26       Impact factor: 6.200

Review 3.  Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies.

Authors:  Brigitte Onténiente; Sowmyalakshmí Rasika; Alexandra Benchoua; Christelle Guégan
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

4.  Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models.

Authors:  Bénédicte Menn; Stéphane Bach; Teri L Blevins; Mark Campbell; Laurent Meijer; Serge Timsit
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

5.  Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat.

Authors:  Mathias Hoehn; Ekkehard Küstermann; James Blunk; Dirk Wiedermann; Thorsten Trapp; Stefan Wecker; Melanie Föcking; Heinz Arnold; Jürgen Hescheler; Bernd K Fleischmann; Wolfram Schwindt; Christian Bührle
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

Review 6.  Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities.

Authors:  Venkata Prasuja Nakka; Anchal Gusain; Suresh L Mehta; Ram Raghubir
Journal:  Mol Neurobiol       Date:  2007-12-08       Impact factor: 5.590

7.  Brief exposure to hyperoxia depletes the glial progenitor pool and impairs functional recovery after hypoxic-ischemic brain injury.

Authors:  Joshua D Koch; Darryl K Miles; Jennifer A Gilley; Cui-Ping Yang; Steven G Kernie
Journal:  J Cereb Blood Flow Metab       Date:  2008-03-12       Impact factor: 6.200

Review 8.  Neurovascular Unit as a Source of Ischemic Stroke Biomarkers-Limitations of Experimental Studies and Perspectives for Clinical Application.

Authors:  Aleksandra Steliga; Przemysław Kowiański; Ewelina Czuba; Monika Waśkow; Janusz Moryś; Grażyna Lietzau
Journal:  Transl Stroke Res       Date:  2019-11-07       Impact factor: 6.800

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.